2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Javier Rodríguez-Carrio, Agata Burska, Philip G. Conaghan, Willem A. Dik, Robert Biesen, Maija Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T. Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie Louise Frémond, Mary K. Crow, Lars Rönnblom, Marjan A. Versnel, Edward M. Vital
Dive into the research topics of '2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice'. Together they form a unique fingerprint.